Fig. 7: FATP2 inhibitor reduced lipoapotosis caused by fibrotic kidneys.
From: Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis
a Bcl-2 and Cleaved caspase 3 protein expression by immunoblot analysis in HK-2 cells. GAPDH sets as loading control. Schematic representation of quantitative data of indicated proteins. b FATP2 inhibitor decreased apoptosis by flow cytometry caused by TGF-β induced fibrogenesis. c TUNEL staining of kidney tissues (green: TUNEL-positive cells, blue: DAPI, x200). These data are calculated from three independent experiments and are expressed as the mean ± SEM. *P < 0.05, ns means no statistical significance.
